Acumen Pharmaceuticals, Inc. (ABOS) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -24.13M | -19.1M | -30.49M | -31.83M | -34.12M | -27.21M | -24.6M | -16.55M | -17.86M | -8.31M | -12.9M | -11.67M | -10.18M | -11.2M | -9.18M | -6.47M | -8.3M | -3.64M | -7.69M | -4.26M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 29.29% | 29.83% | -23.96% | -92.4% | -91.06% | -227.34% | -90.59% | -41.77% | -75.52% | 25.79% | -40.53% | -80.43% | -22.61% | -207.86% | -19.45% | -51.69% | -250.17% | -27.37% | - | - |
| Net Income | -20.74M | -25.14M | -26.45M | -40.95M | -28.8M | -37.15M | -29.77M | -20.54M | -14.87M | -16.5M | -12.96M | -11.61M | -11.31M | -12.87M | -10.71M | -10.15M | -9.13M | -8.35M | -3.9M | -61.36M |
| Depreciation & Amortization | 46K | 740K | 0 | 47K | 45K | 44K | 45K | 45K | 44K | 39K | 40K | 53K | 52K | 49K | 44K | 39K | 37K | 3K | 1K | 0 |
| Stock-Based Compensation | 0 | 2.42M | 0 | 2.5M | 2.47M | 2.34M | 2.34M | 2.47M | 2.48M | 1.63M | 1.6M | 1.52M | 1.39M | 888K | 840K | 715K | 618K | 365K | 304K | 127K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 2.3M | -111K | 2.99M | 298K | -482K | -669K | -948K | -2.29M | -1.45M | 456K | -710K | -300K | -334K | -88K | 191K | 168K | 216K | 270K | -6K | 57.94M |
| Working Capital Changes | -5.74M | 2.99M | -7.03M | 6.28M | -7.36M | 8.22M | 3.73M | 3.77M | -4.07M | 6.05M | -878K | -1.33M | 24K | 814K | 452K | 2.76M | -41K | 4.07M | -4.08M | -973K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.05M | -128K | -1.42M | 1.05M | -4.59M | 3.31M | -1.86M | 1.12M | 1.7M | 17K | -662K | 1.26M | -878K | -444K | 416K | 459K | 121K | 706K | -890K | 354K |
| Cash from Investing | -13.81M | 26.25M | 40.51M | 38.48M | 28.69M | 29.66M | -10.13M | 37.7M | -9.2M | -48.81M | -92M | 11.06M | -41.93M | -20.42M | 55.92M | 8.79M | -5.1M | -10.01M | -94.1M | -6K |
| Capital Expenditures | 0 | 0 | 0 | -9K | -79K | 0 | 0 | -5K | -11K | -14K | -7K | 0 | 0 | -35K | -81K | -36K | -9K | -26K | -8K | -6K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 0 | 0 | 20.39K | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20.39K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 35.74M | 2K | 0 | 0 | -36K | -9K | -42K | -128K | 7.11M | 29.13M | 122.76M | -145K | 0 | 4.18M | -263K | -14K | 0 | 10K | 168.78M | 31.68M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | -739K | 0 | 0 | -739K | 29.52M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 145K | 2K | 0 | 0 | -73K | -9K | -42K | 0 | 7.91M | -390K | 122.76M | -145K | 0 | 3.79M | -263K | -14K | 0 | -3K | 168.78M | 31.68M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -73K | -9K | 0 | 0 | -32K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 35.6M | 0 | 0 | 0 | 37K | 739K | 0 | -128K | -60K | 0 | 0 | 0 | 0 | 392K | 0 | 0 | 0 | 13K | 0 | 0 |
| Net Change in Cash | -2.19M | 7.16M | 10.02M | 6.65M | -5.47M | 2.44M | -34.77M | 21.03M | -19.95M | -27.99M | 17.67M | -751K | -52.1M | -27.44M | 46.47M | 2.3M | -13.4M | -13.64M | 66.99M | 27.41M |
| Free Cash Flow | -24.13M | -19.1M | -30.49M | -31.84M | -34.2M | -27.21M | -24.6M | -16.55M | -17.87M | -8.33M | -12.91M | -11.67M | -10.18M | -11.24M | -9.26M | -6.5M | -8.31M | -3.67M | -7.7M | -4.27M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 29.45% | 29.83% | -23.96% | -92.39% | -91.38% | -226.79% | -90.49% | -41.82% | -75.63% | 25.89% | -39.38% | -79.43% | -22.47% | -206.63% | -20.37% | -52.32% | -250.55% | -28.28% | - | - |
| FCF per Share | -0.38 | -0.32 | -0.50 | -0.53 | -0.57 | -0.45 | -0.41 | -0.28 | -0.30 | -0.14 | -0.24 | -0.28 | -0.25 | -0.28 | -0.23 | -0.16 | -0.21 | -0.10 | -0.20 | -0.11 |
| FCF Conversion (FCF/Net Income) | 1.16x | 0.76x | 1.15x | 0.78x | 1.18x | 0.73x | 0.83x | 0.81x | 1.20x | 0.50x | 1.00x | 1.01x | 0.90x | 0.87x | 0.86x | 0.64x | 0.91x | 0.44x | 1.97x | 0.07x |
| Interest Paid | 0 | 0 | 0 | 740K | 724K | 0 | 0 | 740K | 756K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |